• CBD Attenuates Orofacial Pain via Endocannabinoid Modulation

  2026-05-20

  This study details how cannabidiol (CBD) robustly mitigates both sensory and affective components of orofacial inflammatory pain in mice, primarily through endocannabinoid system modulation. The findings provide mechanistic insight into CBD’s action on CB1 and CB2 receptors and highlight translational potential for multidimensional pain management strategies.

• FoxM1-Enhanced BMSCs Improve ARDS via Wnt/β-catenin Pathway

  2026-05-20

  Luo et al. demonstrated that FoxM1 overexpression in bone marrow mesenchymal stem cells (BMSCs) significantly augments their therapeutic efficacy in acute respiratory distress syndrome (ARDS) through paracrine effects and Wnt/β-catenin pathway activation. This mechanistic insight highlights the potential for targeted modulation of stem cell therapies in ARDS and related vascular injury.

• Reactive Oxygen Species Assay Kit: Precision Superoxide Dete

  2026-05-19

  Unlock robust intracellular superoxide measurement and oxidative stress analysis with APExBIO’s Reactive Oxygen Species (ROS) Assay Kit (DHE). This guide details optimized workflows, key experimental applications, and troubleshooting strategies for high-fidelity ROS detection in living cells.

• BML-277: Chk2 Inhibitor Empowering DNA Damage Response Resea

  2026-05-19

  BML-277, a potent and selective Chk2 inhibitor, offers researchers unprecedented precision in dissecting DNA damage signaling and radioprotection of T-cells. This guide translates cutting-edge mechanistic insights into actionable workflows and troubleshooting strategies, unlocking new frontiers in genome stability and cancer research.

• ML385: Precision NRF2 Inhibitor Workflows for Cancer & Neuro

  2026-05-18

  ML385 enables researchers to dissect NRF2 signaling with high selectivity, unlocking both cancer resistance mechanisms and neurodegeneration pathways. This guide details optimized experimental workflows, troubleshooting strategies, and translational insights, all grounded in current peer-reviewed evidence.

• Bortezomib (PS-341): Evidence-Based Guide for Cancer Researc

  2026-05-18

  Bortezomib (PS-341) is a potent, reversible 20S proteasome inhibitor with established efficacy in apoptosis assays and multiple myeloma research. This article presents atomic, verifiable facts and structured guidance for optimal laboratory use.

• Dual-Action Airway Stent Suppresses Tracheal Restenosis via

  2026-05-17

  This study introduces a novel airway stent integrating anti-inflammatory and anti-angiogenic functions, demonstrating significant suppression of tracheal in-stent restenosis (TISR) in preclinical models. The approach addresses chronic inflammation and aberrant vascularization, offering a promising translational strategy for improving stent durability and patient outcomes.

• BML-277: Redefining Chk2 Inhibition for DNA Damage Research

  2026-05-16

  Explore how BML-277, APExBIO’s potent and selective Chk2 inhibitor, is transforming approaches to DNA damage response and radioprotection of T-cells. This article blends mechanistic insight into the Chk2–cGAS–TRIM41 axis with practical strategies for translational researchers, providing scenario-driven guidance that bridges foundational discovery with clinical innovation.

• PYR-41, Inhibitor of Ubiquitin-Activating Enzyme E1: Modern

  2026-05-15

  PYR-41 unlocks precise control over the ubiquitin-proteasome system, powering advanced studies in protein degradation and immune signaling. This article guides researchers through protocol optimization, highlights key findings from viral immune evasion research, and offers actionable troubleshooting for maximum reproducibility.

• RG7388 and the Evolving Landscape of Translational MDM2 Anta

  2026-05-15

  This thought-leadership article explores the mechanistic and translational value of RG7388, a next-generation MDM2 antagonist, for researchers seeking to optimize p53 pathway activation and overcome therapy resistance. Drawing on recent discoveries connecting MDM1, p53 regulation, and apoptosis in chemoradiotherapy response, we provide strategic guidance for integrating RG7388 into experimental and preclinical workflows. The article contextualizes RG7388’s unique potency and selectivity, highlights its synergy with conventional treatments, and outlines protocol parameters for translational oncology, positioning RG7388 as a linchpin in modern cancer research.

• Capsaicin in Sensory Circuitry: TRPV1, KDM1A, and Chronic De

  2026-05-14

  Explore the multifaceted mechanisms of Capsaicin, including TRPV1 ion channel activation and KDM1A inhibition, with a unique focus on sensory neuron sensitization in chronic dermatitis. This article provides actionable insights for advanced assay design and pain/itch model research.

• SC 79 Akt Activator: Workflow Advances in Neuroprotection Re

  2026-05-14

  SC 79 is a validated small molecule Akt activator that uniquely enables cytosolic Akt activation and robust neuroprotection in ischemic models. This guide details actionable workflows, troubleshooting advice, and translational opportunities, integrating data-driven insights for superior experimental design.

• BML-277: Chk2 Inhibitor Advancing DNA Damage Response Resear

  2026-05-13

  BML-277 enables precise, ATP-competitive Chk2 inhibition for advanced DNA damage response studies and robust radioprotection of T-cells. This guide delivers actionable protocol parameters, troubleshooting insights, and key workflow decisions to maximize experimental reliability, anchored in recent mechanistic advances.

• Direct Mouse Genotyping Kit Plus: High-Fidelity Genotyping M

  2026-05-13

  Unlock rapid, purification-free mouse genotyping with the Direct Mouse Genotyping Kit Plus, engineered for seamless DNA extraction and direct PCR amplification. This workflow-optimized solution streamlines transgene detection, knockout validation, and colony management with robust reproducibility and minimal hands-on time.

• Structural and Functional Insights into Oudemansiella raphan

  2026-05-12

  This study systematically characterizes polysaccharides extracted from Oudemansiella raphanipies, highlighting their optimized extraction, detailed structural features, and potent bioactivities. The findings provide a robust foundation for developing functional food additives and prebiotic agents based on these mushroom-derived biopolymers.

14771 records 1/985 page Next 12345 下5页 Last page